# Gender-Based Differences in Heart Failure Hospitalizations Among Patients With Heart Failure Treated With Spironolactone

> **NCT06641284** · — · COMPLETED · sponsor: **Ahmad Abdullah Salawi** · enrollment: 509 (actual)

## Conditions studied

- Heart Failure
- Heart Failure With Reduced Ejection Fraction
- Heart Failure NYHA Class II
- Heart Failure NYHA Class III
- Heart Failure NYHA Class IV

## Interventions

- **DRUG:** Spironolactone

## Key facts

- **NCT ID:** NCT06641284
- **Lead sponsor:** Ahmad Abdullah Salawi
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2023-10-01
- **Primary completion:** 2024-10-15
- **Final completion:** 2024-10-15
- **Target enrollment:** 509 (ACTUAL)
- **Last updated:** 2025-03-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06641284

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06641284, "Gender-Based Differences in Heart Failure Hospitalizations Among Patients With Heart Failure Treated With Spironolactone". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT06641284. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*